Scribe Therapeutics
1 follower
‌
Scribe is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.
Industries
Headquarters
Employees
Links
Org chart
Benjamin L. Oakes
Collapse
Brett T. Staahl
Co-Founder & VP, External Innovation
David Parrot
CFO
Svetlana Lucas
Chief Business Officer
Richard Hector
Head of IP
Vera Switek
VP, Talent
Sunny Mok
VP, Program Management
Kristina Oresic Bender
Vice President Translational Sciences
Shilpa Shroff
VP, Process Sciences
Michelle Eggers
Senior Director, Preclinical Study Management
Ed Sterling II
Director, Information Technology At Scribe Therapeutics
Director, Laboratory And Facilities Operations
Vacant position
